Large Volume Bupivacaine 0.5% Versus Small Volume in Elective Caesarean Section

Cairo University (CU)

Status: Unknown

Conditions: Spinal Anesthesia

Treatments: Drug: intrathecal 15 mg bupivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT02937792

3 ml bupivacaine

Details and patient eligibility

About

To test the safety of high dose spinal in elective CS after prolonged sitting position.

Full description

This is a prospective double-blind randomized study, designed to include cases in two groups (using epical program for sample size calculation), one study groups and one control group (parallel). Each group should have at least 30 female patients scheduled for elective caesarean section with a total of 60 cases.

Enrollment: 30 estimated patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Full term pregnant female indicated for the elective section under spinal anesthesia with no history of medical importance

Exclusion criteria

• Urgent cases, emergency cases, adverse medical history, anticoagulant treatment, associated pregnancy complication, failed spinal, surgical complication or refusal

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

30 participants in 2 patient groups

CONTROL

No Intervention group

Description:

one with intrathecal 12.5 mg bupivacaine

experimental

Experimental group

Description:

one group with intrathecal 15 mg bupivacaine

Treatment:

Drug: intrathecal 15 mg bupivacaine